CLOV Clover Health Investments, Corp.
Healthcare$3.61+1.69%ClosedMarket Cap: $1.87B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.46
P/S
0.83
EV/EBITDA
-30.19
DCF Value
$-6.44
FCF Yield
3.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
18.4%
Operating Margin
-2.6%
Net Margin
-2.6%
ROE
-17.1%
ROA
-8.2%
ROIC
-15.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $749.2M | 21.3% | $27.3M | $27.3M | $— | — |
| Q4 null | $487.7M | 15.2% | $-49.3M | $-49.3M | $— | — |
| FY null | $1.92B | 18.5% | $-85.5M | $-85.5M | $— | — |
| Q3 null | $496.6M | 14.7% | $-24.4M | $-24.4M | $— | — |
| Q2 null | $477.6M | 20.9% | $-10.6M | $-10.6M | $— | — |
| Q1 null | $462.3M | 23.6% | $-1.3M | $-1.3M | $— | — |
| Q4 null | $337.0M | 27.9% | $-21.4M | $-22.1M | $— | — |
| FY null | $1.37B | 26.6% | $-45.7M | $-43.0M | $— | — |
| Q3 null | $331.0M | 24.5% | $-8.8M | $-9.2M | $— | — |
| Q2 null | $356.3M | 30.3% | $7.2M | $7.4M | $— | — |
| Q1 null | $346.9M | 23.6% | $-22.7M | $-19.2M | $— | — |
| Q4 2023 | $510.3M | 12.2% | $-65.7M | $-70.5M | $-0.15 | — |